Amtech Esters IPO Day 2: GMP ₹7 (+₹2)

Welcome back to our daily check-in on the Amtech Esters SME IPO on the BSE! As we wrap up Day 2 of the subscription period, it’s time to dive into the latest numbers and see how the market’s sentiment is shaping up. While the official subscription figures are still showing zero across the board, the Grey Market Premium (GMP) has been ticking upwards, offering a glimmer of excitement for potential investors. The IPO, which opened on September 9th and closes on September 11th, is offering shares at ₹75 each, with an expected listing price of ₹82.

Subscription Status

As of the end of Day 2, the subscription numbers for Amtech Esters are showing 0x across all categories: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This might seem concerning at first glance, and it’s true that seeing zero interest from any segment can be a red flag. Typically, by the second day, we’d expect to see at least some initial traction, especially from retail investors who often jump in early. The absence of bids across the board could indicate a wait-and-watch approach from investors, or perhaps a lack of broad awareness about the issue just yet. However, it’s important to remember that SME IPOs sometimes see a surge of interest on the final day, so this isn’t necessarily a death knell. We’ll be keeping a very close eye on Day 3 for any signs of life.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). This is where things get a bit more interesting for Amtech Esters. Yesterday, the GMP stood at ₹5. Today, we’ve seen a healthy increase, with the current GMP reported at ₹7. This ₹2 jump is encouraging. It suggests that even without concrete subscription data, there’s a growing positive sentiment in the unofficial market. A GMP of ₹7 on an issue price of ₹75 implies an expected listing price of ₹82 (₹75 + ₹7). This aligns perfectly with the upper end of initial expectations and indicates that market makers are anticipating a decent debut for the company. This upward trend in GMP is a good sign, signaling that demand might be building, even if it hasn’t translated into official bids yet.

Should You Apply?

So, the million-dollar question: should you be applying for Amtech Esters? It’s a bit of a mixed bag right now. On one hand, the complete lack of subscription figures on Day 2 is a point of caution. Investors typically want to see some level of oversubscription, especially in the retail and NII categories, to gauge genuine interest. However, that said, the rising GMP is a definite positive. It shows that there’s a segment of the market that believes in the company’s prospects and is willing to pay a premium for its shares. The increase from ₹5 to ₹7 in GMP is a good indicator of this growing confidence. Remember, the lot size for this IPO is 1600 shares, with an issue price of ₹75, meaning a single lot requires an investment of ₹1,20,000. For retail investors, this is a significant commitment. As per SEBI guidelines, it’s always advisable to conduct thorough research on the company’s fundamentals, its business model, and its future growth prospects before making any investment decisions. Don’t just rely on GMP alone. The bottom line is, if you’re comfortable with the risk associated with SME IPOs and believe in Amtech Esters’ long-term potential, the current GMP offers some comfort. However, if you prefer to see concrete subscription numbers before committing your capital, you might want to wait until Day 3 or even the closing hours to make your decision. You can View Full Amtech Esters IPO Details for more in-depth information.